The Geneva Papers on Risk and Insurance (2004) 29, 728–737. doi:10.1111/j.1468-0440.2004.00314.x
Scenarios for Change in Cancer Treatment 2004-2010: Impacts on Insurance
Nick Bosanquet1 and Karol Sikora2
- 1Professor of Health Policy, Imperial College School of Science, Technology and Medicine, London, UK
- 2Visiting Professor of Cancer Medicine, Imperial College School of Science, Medicine and Technology, Hammersmith Hospital, London, UK
Correspondence: Nick Bosanquet, Imperial College School of Science, Medicine and Technology, London SW7 2AZ.
Top of page
Abstract
The prevalence of cancer is set to increase sharply with new pressures for change in treatment and prevention. This paper reviews evidence on likely changes in treatment costs, which will increase with improved survival, and on the distribution of costs to society. It then presents a profile of likely change in technology. A concluding section draws out implications for service design and an enhanced role for insurers.
